Navigation Links
Shire plc: IFRS Results for the Year Ending December 31, 2007
Date:3/25/2008

- 40.6

__________ __________

Profit for the year 82.4 56.2

__________ __________

5

Earnings per share (expressed in cents per

share)

- Basic 15.3c 11.2c

- Diluted 15.0c 11.0c

__________ __________

Earnings per share from continuing 5

operations (expressed in cents per share)

- Basic 15.3c 3.1c

- Diluted 15.0c 3.0c

__________ __________

The accompanying notes are an integral part of these consolidated financial statements.

The profit for the year is all attributable to the equity holders of the parent.

Consolidated statement of recognised income and expense

2007 2006

Year to December 31, Notes US$M US$M

________ __________ __________

Profit for the year 82.4 56.2

__________ __________

Exchange differences on translation of

foreign operations 24.2 26.7

Unrealised holding loss on

available-for-sale securities, net of taxes

of US$5.2 million (2006: US$nil) (16.5) (1.8)

Realised gain on available-for-sale

securities
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%
2. Shire plc: Correction Re Website
3. Shires ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
4. Shire Engages Palio
5. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
6. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
7. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
8. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
9. Shire plc: Board Changes
10. David Mott Appointed Non Executive Director at Shire
11. Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... , May 21, 2013  Personal Genome ... use its proprietary methodologies and expertise in genomic ... kinase targets in collaboration with Blueprint Medicines.  PGDx ... at identifying genomic alterations in tumors, and Blueprint ... kinase inhibitors for a genetically defined patient population. ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Revolutionary Science, ... automatic colony counter, announced today that they have expanded ... products , the IncuCount, IntelliCount, InCount and ImpressCount. ... sophistication are especially useful in food microbiology and pharmaceutical ... an updated look. A bright white enclosure with ...
(Date:5/21/2013)... 21, 2013 Inflamax scientists worked ... ITN to design the study, which will provide ... clinical models used in the study of allergy ... Allergen Challenge (NAC) models. Although both the models ... to date no direct comparison between the allergic ...
(Date:5/21/2013)... MA (PRWEB) May 21, 2013 Possible mold ... And so, according to a report from eagletribune.com posted May ... mold. In case the result is positive, My Cleaning Products ... using harmful chemical ingredients. , It was said in the ... re-infestation in the campus sparked after a first-grade classroom ...
Breaking Biology Technology:Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 3Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 3
... that has sped to the finals in the Governor's ... annual flu vaccine hoopla, among other things. , ,Founders Curtis ... drugs based on antiviral peptides discovered in Brandt's lab. One ... targets some sexually transmitted viruses such as HIV and herpes. ...
... human thumbnail, but they can hold over a half of ... technology offers a view of so many tiny bits of ... 30,000 genes of the human genome, which are one of ... tiny dots of sample material on them, give scientists a ...
... Bextra from the marketplace clearly jolted both Pfizer and the market. ... ago and its stock has declined from $38 per share a ... recently moved up to the $27 level. , ,This activity still ... months. , ,Though Pfizer still leads the industry with a market ...
Cached Biology Technology:UW-Madison spinoff Pedrus finds more to business planning than good science 2UW-Madison spinoff Pedrus finds more to business planning than good science 3Madison biochip research offers geneticists a big view through a small window 2Madison biochip research offers geneticists a big view through a small window 3Why are new drugs failing? 2Why are new drugs failing? 3Why are new drugs failing? 4Why are new drugs failing? 5Why are new drugs failing? 6
(Date:5/21/2013)... have found that a class of pharmaceuticals can both ... The drugs, known as "TSPO ligands," are currently used ... the effects of TSPO ligand in young adult mice ... aged mice when pathology was quite severe," said lead ... Gerontology. "TSPO ligand reduced measures of pathology and improved ...
(Date:5/21/2013)... stores, phosphatidylserine is a natural food supplement produced ... cognition and slow memory loss, it,s a popular ... a team headed by Prof. Gil Ast and ... of Human Molecular Genetics have discovered ... genes involved in degenerative brain disorders, including Parkinson,s ...
(Date:5/21/2013)... decades, scientists have developed many devices that can reopen ... generally effective, each of these treatments has drawbacks, including ... from MIT analyzes the potential usefulness of a new ... drug-releasing stents, but may pose fewer risks. With this ... for only a brief period, during which it releases ...
Breaking Biology News(10 mins):Drugs found to both prevent and treat Alzheimer's disease in mice 2Common food supplement fights degenerative brain disorders 2Evaluating a new way to open clogged arteries 2Evaluating a new way to open clogged arteries 3
... University of Southern California have made a significant breakthrough ... a synthetic brain. They have built a carbon nanotube ... of a neuron, the building block of the brain. ... Parker and Professor Chongwu Zhou in the USC Viterbi ...
... treating disease. But can they work better, and safer? ... challenge of administering therapeutics in a way that boosts their ... their potential damage to healthy tissue. The ... drugs and release them directly into cells holds great potential ...
... Carolina State University have discovered how fat, oil and ... it turns into soap! The hardened deposits, which can ... found that FOG deposits in sewage collection systems are ... from FOG into, basically, a huge lump of soap," ...
Cached Biology News:Researchers create functioning synapse using carbon nanotubes 2Scientists engineer nanoscale vaults to encapsulate 'nanodisks' for drug delivery 2Scientists engineer nanoscale vaults to encapsulate 'nanodisks' for drug delivery 3Researchers find fat turns into soap in sewers, contributes to overflows 2